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Increased binding and defective migration across fibronectin of cycling
hematopoietic progenitor cells
Olivier Giet, Dirk R. Van Bockstaele, Ivano Di Stefano, Sandra Huygen, Roland Greimers, Yves Beguin, and Andre´ Gothot
Engraftment of hematopoietic progenitor
cells has been shown to decrease during
cell cycle transit. We studied cell cycle–
associated changes in adhesion and mi-
gration of mitotically activated cord blood
CD341 cells. Migration toward medium
conditioned by the stromal-derived factor-
1–producing cell line MS-5 was studied in
bovine serum albumin– and fibronectin
(Fn)–coated transwells. Migration was re-
duced in cycling CD341 cells and long-
term culture-initiating cells (LTC-ICs) com-
pared with their noncycling counterparts
across Fn but not across bovine serum
albumin. Conversely, Fn binding was
higher in cycling CD341 cells and LTC-ICs
compared with noncycling progenitor
cells, while adhesion of both subsets to
bovine serum albumin was undetectable.
The contribution of a4 and a5 integrins in
mediating adhesion and migration of acti-
vated CD341 cells onto Fn was analyzed
by neutralization experiments. While a4-
mediated Fn binding decreased during
G2/M, a5 integrin–mediated adhesion in-
creased during transit from G0/G1 to S
and G2/M phases. As for migration, the
contribution of a4 integrin was similar in
all phases, whereas a5-directed migra-
tion was lower in G2/M compared with
G0/G1 and S phases. Defective migration
of cycling CD341 cells was not due to
differences in a5 integrin expression. In
conclusion, chemotaxis across Fn is less
efficient in cycling progenitor cells in
correlation with an increased Fn binding
capacity. In addition, a4 and a5 integrin
functions are independently modulated
during cell cycle transit. (Blood. 2002;99:
2023-2031)
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Introduction
Recent studies have indicated that entry of cultured hematopoietic
stem cells (HSCs) into active phases of the cell cycle reduces their
homing ability and subsequent long-term repopulating potential.
First, several investigators reported an engraftment defect of stem
cells that had been induced to cycle either in vivo or ex vivo.1-4
Habibian et al5 later demonstrated that murine stem cells transiting
through S and G2 phases acquired an engraftment defect that was
reversible after the completion of mitosis. Szilvassy et al6 also
observed a loss of long-term engraftment associated with cell cycle
activation. As for human stem cells, we showed that transition from
G0 to G1 of a first cell cycle resulted in a decrease of engraftment
capacity in immunodeficient mice.7 Also, Glimm et al8 provided
evidence that expanded human HSCs were ineffective in repopula-
tion assays during S and G2/M phases. To date, the explanation at
the cellular and/or molecular level of these findings has not
been provided.
Specific interactions of HSCs with adhesion molecules ex-
pressed by endothelial and stromal cells have been studied by
numerous groups. A model of HSC homing has progressively
emerged.9,10 After initial rolling on endothelial E and P selectins,
HSCs adhere to the luminal face of bone marrow endothelial cells
through very late antigen (VLA)–4/vascular cell adhesion mole-
cule-1 and lymphocyte function-associated antigen-1/intercellular
cell adhesion molecule-1 interactions. Adherent HSCs transmigrate
through the basal lamina via interactions of surface VLA-4 and
VLA-5 with fibronectin (Fn). HSCs undergo chemotactic intra-
medullary migration in response to stromal-derived factor (SDF)–1
to reach adequate “niches” formed by bone marrow stromal cells
expressing, among other ligands, vascular cell adhesion mole-
cule-1 11,12 and Fn.13
Fn is recognized by 2 different b1 integrins expressed by HSCs:
VLA-4 and VLA-5. Previous studies have highlighted a dominant
role either for VLA-4 14 or for VLA-5 15 in Fn binding of HSCs.
Interaction of HSCs with Fn is a tightly regulated process
controlled by cytokines such as stem cell factor (SCF), interleu-
kin-3, and thrombopoietin,16-19 which have been reported to
modulate both VLA-4 and VLA-5 during short-term ex vivo
culture, influencing adhesion20,21 and migration onto Fn-coated
surfaces.22 Also, Fn was reported to enhance transmigration of
CD341 cells toward SDF-1.23 Altogether, not only Fn is present in
key areas traversed by HSCs during the homing process24 but, also,
interactions of HSC with Fn are modulated through changes in
integrin affinity or expression by a vast number of stimuli and
therefore present a broad potential for modulation. Therefore, an
interesting working hypothesis was to test whether cell cycle–
related differences in homing were related to regulation of
Fn binding.
Relationships between cell cycle transit and integrin expression
and/or function were suggested by several investigators,25,26 includ-
ing our group.27 In nonhematopoietic tissues, it has been well
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established that when adhesion is maximal cells are immobilized
and unable to migrate, while lower adhesion force may allow cell
locomotion.28-30 In this paper, we investigated whether adhesion
and migration of committed progenitor cells and primitive long-
term culture-initiating cells (LTC-ICs) were modulated by cell
cycle transit. Our data show that migration across Fn is defective
while static adhesion to Fn is increased in cycling progenitor cells
as compared with their noncycling counterparts.
Materials and methods
Cells
After obtaining informed consent, cord blood (CB) samples were obtained
following full-term vaginal delivery according to the guidelines established
by the Ethical Committee of the University of Lie`ge. Mononuclear low-
density cells were isolated by centrifugation over Ficoll-Paque (Amersham
Pharmacia Biotech, Uppsala, Sweden). CB CD341 cells were purified by
immunomagnetic selection using magnetic-activated cell separation CD34
isolation kits (Miltenyi Biotech, Auburn, CA) as per the manufacturer’s
instructions. CD341 cell purity in the final product always exceeded 97%.
Short-term suspension cultures
CD341 cells were plated in a serum-free medium consisting of Iscoves
medium supplemented with 10 mg/mL bovine serum albumin (BSA), 10
mg/mL bovine insulin, 200 mg/mL transferrin (all from Stem Cell Technolo-
gies, Vancouver, BC), 2 mM alanyl-glutamine, 1% (vol/vol) cholesterol-
rich lipids, 1 mM sodium pyruvate (all from Sigma, St Louis, MO), 100
U/mL penicillin, 100 mg/mL streptomycin, and 5 3 1022 mM 2-mercapto-
ethanol (all from Biowhittaker, Petit-Rechain, Belgium). Cells were
stimulated by a combination of 100 ng/mL SCF (Amgen, Thousand Oaks,
CA), 50 ng/mL thrombopoietin (Amgen), and 100 ng/mL flt3-ligand (FL;
R&D Systems, Abingdon, United Kingdom) and maintained at 37°C in a
100% humidified atmosphere with 5% CO2. The percentage of CD341 cells
up to 48 hours in culture was always more than 95%.
MS-5 conditioned medium
The stromal MS-5 cell line31 was plated in 25 cm2 flasks in 7 mL
a-minimum essential medium (a-MEM; Biowhittaker) supplemented with
10% fetal bovine serum (Life Technologies, Paisley, United Kingdom) at
37°C. At confluence, the medium was completely replaced with fresh
medium. After 7 days, the conditioned medium (MS-5 CM) was harvested,
spun at 2000g for 10 minutes, and the supernatant frozen in small aliquots.
Concentration of SDF-1 in MS-5 CM was assayed using the Quantikine
human SDF-1 immunoassay kit (R&D Systems). The kit cross-reacts with
mouse SDF-1 whose amino acid sequence is 99% homologous to that of
human SDF-1. SDF-1 concentration was on average 76.5 6 7.5 ng/mL in
MS-5 CM batches used for these studies.
Migration assays
Migration assays were performed in 6.5-mm diameter 5-mm pore transwells
(Costar, Cambridge, MA). Transwell filters were coated with 10 mg/cm2 Fn
(Sigma) in phosphate-buffered saline (PBS; Biowhittaker). Control filters
were coated with 1% fraction V BSA (Life Technologies) in PBS. Coating
was done overnight at 4°C. The coating solution was aspirated and replaced
by a 1% BSA solution in PBS at 37°C for 30 minutes to block nonspecific
binding sites. After 2 washes in RPMI 1640 with HEPES 25 mM, 2 3 105
cells were plated in 100 mL Myelocult (Stem Cell Technologies) in the
upper chamber of the transwell. The bottom compartment was filled with
600 mL MS-5 CM or a-MEM with 10% fetal bovine serum as control
medium. After incubation at 37°C during 3 hours, nonmigrating and
migrating cells were harvested from the top and bottom compartments,
respectively. Nonmigrating cells were recovered by 2 washes each consist-
ing of a 5-minute treatment with an enzyme-free cell dissociation buffer
(Life Technologies) at 37°C followed by vigorous pipetting. In some
experiments, nonmigrating cells remaining loosely adherent to the interface
filter or floating in the upper chamber (ie, nonadherent cells) were
separately harvested from cells that were firmly adherent to the filter (ie,
adherent cells). Nonadherent cells were recovered by 2 gentle washes with
PBS 1% BSA, and adherent cells were harvested after a 5-minute treatment
with cell dissociation buffer. Harvested cells in all fractions were counted in
Fuchs-Rosenthal hemacytometers (total volume 3.2 mL). The percentage of
cells in each fraction was calculated relative to the total number of cells
plated. In selected experiments, stimulated CD341 cells were preincubated
with neutralizing antibodies against VLA-4 (clone P4C2, Life Technolo-
gies), VLA-5 (clone P1D6, Life Technologies), CXCR4 (clone 12G5,
Pharmingen, San Diego, CA), or isotype-matched mouse immunoglobulin
G (IgG) (Pharmingen) during 30 minutes at 4°C prior to the migration assay.
Adhesion assays
Fn (Sigma) was adsorbed at 4°C to wells of nontissue culture–treated
24-well plates (Becton Dickinson, Erembodegem, Belgium) at 10 mg/cm2,
except where indicated, in PBS. Coating was done in the same conditions as
described above for transwell filters, after which 1 3 105 to 2 3 105
cultured CD341 cells were plated in RPMI 1640 containing 0.1% BSA at
37°C. After 1-hour incubation, nonadherent cells were harvested by 2
standardized washes using warm PBS 1% BSA. Adherent cells were then
recovered after a 5-minute incubation in cell dissociation buffer at 37°C
followed by vigorous pipetting. Adherent and nonadherent cells were
counted in Fuchs-Rosenthal hemacytometers. Percent adhesion was calcu-
lated relative to the total number of cells plated. Adhesion on BSA-coated
control plates was less than 2%. In some experiments, CD341 cells were
preincubated with blocking antibodies anti–VLA-4, anti–VLA-5, or control
mouse IgG during 30 minutes at 4°C prior to the adhesion assay.
Determination of adhesion and migration of CD341 cells in
different phases of the cell cycle
Cells recovered in various fractions after adhesion or migration assays were
incubated in PBS 0.6% IGEPAL CA-630 (Sigma) containing 50 mg/mL
propidium idodide (PI) and 1 mg/mL ribonuclease (Boehringer, Mannheim,
Germany). After a 30-minute incubation on ice in the dark, cells were run
on a FACSort flow cytometer collecting FL-2 channel values. The
percentage of cells in the different phases of the cell cycle was determined
with Modfit software (Becton Dickinson). Absolute numbers of adherent
cells in G0/G1, S, or G2/M were obtained by multiplying the percentage of
adherent cells by the percentage of cells in G0/G1, S, or G2/M in the
adherent fraction. The same procedure was used to obtain numbers of
G0/G1, S, and G2/M cells in the nonadherent, migrating, and nonmigrating
fractions. The migratory activity of cells in G0/G1, S, and G2/M was
calculated from the ratio of the absolute number of migrating cells in G0/G1,
S, or G2/M and the total number of cells (migrating plus nonmigrating) in
G0/G1, S, or G2/M. Similarly, binding capacity of cells in G0/G1, S, and
G21M was obtained by dividing the number of adherent cells in G0/G1, S,
or G21M by the total number of cells (adherent plus nonadherent) in the
corresponding phase.
Colony-forming cell and LTC-IC assays
Colony-forming cell assays were performed in Methocult H4435 (Stem
Cell Technologies), which is supplemented with 50 ng/mL SCF, 20 ng/mL
granulocyte-macrophage colony-stimulating factor, 20 ng/mL interleu-
kin-3, 20 ng/mL interleukin-6, 20 ng/mL granulocyte colony-stimulating
factor, and 3 U/mL erythropoietin. Absolute frequencies of LTC-ICs in cell
suspensions recovered after migration assays were determined by limiting
dilution analysis over M2-10B4 fibroblast feeder cells.32 Briefly, the
fibroblast feeder cell line M2-10B4 (American Type Culture Collection,
Rockville, MD) was cultured in RPMI 1640 with 10% FCS. Cells were
irradiated at 50 Gy and plated in 96-well plates at 15 000 cells per well in
100 mL Myelocult (Stem Cell Technologies). Within a week, test cells were
plated in limiting dilution at 24 wells per cell dose in another 100 mL
Myelocult and maintained at 33°C in a 100% humidified atmosphere
containing 5% CO2, with weekly half-medium change. After 5 to 6 weeks,
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medium was carefully aspirated from each well, followed by the addition of
200 mL Methocult H4435. After an additional 2 weeks, wells were scored
for the presence or absence of hematopoietic colonies, and the frequency of
LTC-ICs was calculated using the maximum likelihood estimator.33
To determine the percent migration of cycling and noncycling LTC-ICs,
hydroxyurea (HU) killing tests were performed as previously described,27
prior to migration assays. Briefly, 1 3 105 to 2 3 105 CD341 cells were
treated with 2 mg/mL HU (Sigma) in Iscoves medium with 1% BSA during
1 hour at 37°C. Control cells were incubated in medium only. After 2
washes in Iscoves medium with 1% BSA, cells were transferred in
transwells and allowed to migrate during 3 hours. Exposition of the cells to
HU did not interfere with migration (37.9% 6 4.5% migration in HU-
treated cells vs 36.6% 6 4.5% migration in control cells, n 5 7). HU did
not modify VLA-4, VLA-5, and CXCR4 expression or alter adhesion to Fn
(data not shown). Migrating and nonmigrating cells were then replated in
limiting dilution in LTC-IC assays. In each fraction, the percentage of
cycling LTC-ICs was estimated from the proportion of LTC-ICs killed by
HU treatment relative to the percentage of LTC-ICs in control cells.
Migration of cycling LTC-ICs was calculated from the ratio of the number
of cycling LTC-ICs in the migrating fraction and the total number
(migrating plus nonmigrating) of cycling LTC-ICs. Similarly, to calculate
the migratory activity of noncycling LTC-ICs, the number of noncycling
LTC-ICs in the migrating fraction was divided by the total number
(migrating plus nonmigrating) of noncycling LTC-ICs.
Flow cytometric analysis of integrin and CXCR4 expression
Fluorescein isothiocyanate (FITC)–conjugated anti–VLA-4 (CD49d, Coulter
Immunotech, Marseille, France) and FITC-conjugated anti–VLA-5 (CD49e,
Pharmingen) were used in combination with phycoerythrin (PE)–
conjugated anti-CXCR4 (Pharmingen). Cells were incubated with antibod-
ies or isotype-matched control IgG for 20 minutes on ice in the dark. Cells
were washed in PBS 1% calf serum (Biowhittaker) and fixed in PBS 1%
paraformaldehyde (Sigma). Data were acquired on a FACSort flow
cytometer (Becton Dickinson) and analyzed using CellQuest software
(Becton Dickinson). CXCR41 cells were identified as those displaying a
fluorescence above 99% of the isotypic control. Integrin density was
expressed as the mean channel fluorescence ratio (MCFR) defined as MCF
of integrin expression divided by MCF of fluorescence-matched
isotypic control.
Flow cytometric cell sorting
Cultured CD341 cells were sorted on the basis of cell cycle status. Briefly,
cells were incubated in serum-free medium supplemented with 5 mg/mL
Hoechst 33342 (Molecular Probes, Eugene, OR) during 30 minutes at 37°C.
Cells in G0/G1 or in S/G2/M were sorted by a FACS Vantage (Becton
Dickinson) equipped with a multiline UV laser (Innova Enterprise Ion
Laser, Coherent, Santa Clara, CA) (351-364 nm) providing excitation for
Hoechst. Hoechst signal was detected through a 424 6 22 nm bandpass
filter. The purity of sorted cells was confirmed by DNA staining of sorted
cells with PI and always exceeded 90%.
For cell sorting on the basis of VLA-5 expression, cultured CD341 cells
were labeled with biotinylated anti–VLA-5 (clone VC5; Pharmingen) and
with streptavidin-FITC (Pharmingen), each step for 20 minutes at 4°C.
Gating was set to include the lower and upper 20% of the VLA-5 histogram.
Contamination between VLA-5low and VLA-5high fractions was 5% to 10%.
In selected experiments where CD341 cells were sorted simultaneously
according to the level of VLA-5 expression and cell cycle status, Hoechst
33342 was added to anti–VLA-5–stained cells at the final concentration of 5
mg/mL during 30 minutes at 37°C, prior to cell sorting.
Statistical analysis
Results are reported as mean 6 standard error of the mean (SEM).
Comparisons were made using Student t tests. All P values are 2-sided.
Results
Effect of fibronectin on the motility of cell cycle–activated
progenitor cells
It has been well established that CB progenitor cells reside in the
G0/G1 phase of the cell cycle when freshly isolated.34 A 48-hour ex
vivo culture in the presence of SCF, thrombopoietin, and FL was
used to induce a large proportion of the cells into active phases of
the cell cycle (. 40% of cells in S/G2/M in all experiments). The
cloning efficiency of stimulated CD341 cells was estimated in
methylcellulose assays and was 90.5% 6 1.8% (n 5 21). This
must be compared with the cloning efficiency of freshly isolated
CB CD341 cells, which was 40.5% 6 3.5% in historical controls.
An increase in cloning efficiency after a short-term cytokine
stimulation has been observed repeatedly in our laboratory and is
due to the loss of nonclonogenic cells quickly after culture
initiation. The use of a highly pure population of clonogenic
progenitors was essential to ascertain that the cells being studied
were at the same level of differentiation.
Migratory activity of cultured CD341 cells was assayed in
transwells (Figure 1). Spontaneous migration toward control
medium was observed in 5.5% 6 1.4% and 18.0% 6 2.0% of the
cells through BSA- and Fn-coated filters, respectively (P , .05).
Migration toward MS-5 CM was increased up to 26.0% 6 3.4%
through BSA (P , .05 compared with control medium) and up to
41.0% 6 3.3% through Fn (P , .05, compared with control me-
dium). Therefore, migration of stimulated CD341 cells was
dependent both on a chemoattractant gradient and on the presence
of an adhesive substratum.
We confirmed that migration toward MS-5 CM was dependent
on the presence of SDF-1. The expression of SDF-1 receptor,
CXCR4, was measured by FACS analysis in cells recovered in the
migrating and nonmigrating fractions (Figure 2). Migration toward
MS-5 CM was, in part, dependent on the presence of CXCR4
because 46.1% 6 5.6% of the cells migrating through an Fn
interface were CXCR41 as compared with 23.6% 6 4.4% for
nonmigrating cells (P , .05, n 5 7). As negative control, spontane-
ous migration toward control medium was not related to differ-
ences in CXCR4 expression: 26.6% 6 6.9% of migrating and
29.6% 6 5.6% of nonmigrating cells were CXCR41, respectively
Figure 1. Transmigration of ex vivo–cultured CD341 cells toward MS-5 CM was
enhanced by Fn. CB CD341 progenitor cells were stimulated ex vivo during 48 hours
and transferred to the top chamber of transwells coated with Fn (10 mg/cm2) or BSA
(1%). MS-5 CM or control medium (a-MEM with 10% fetal bovine serum) was placed
in the bottom chamber. Cells were allowed to migrate during 3 hours at 37°C (n 5 6).
*Percent migration was higher across Fn than across BSA (P , .05). **MS-5 CM
stimulated migration across both matrices (P , .05).
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(P . .05). Migration toward MS-5 CM was inhibited by a neutral-
izing antibody against CXCR4, across either Fn (48.5% inhibition)
or BSA (52.6% inhibition).
To better characterize the effect of Fn, cells remaining in the top
chamber after 3 hours of transmigration were fractionated into
nonadherent and adherent fractions. Less than 2% adherent cells
could be recovered from a BSA-coated filter (n 5 10). In contrast,
in the presence of 10 mg/cm2 Fn, 10.8% 6 1.6% (n 5 14) of input
cells were strongly adherent to the transwell filter. With increasing
Fn concentrations (Figure 3), the proportion of migrating cells rose
from 27.9% to 44.9%, together with the appearance of an adherent
fraction (up to 12.9% of total input cells at a 20 mg/cm2 Fn
concentration). Thus, at high Fn concentrations, although the
proportion of migrating cells increased, a significant percentage of
nonmigrating cells was fully adherent to the transwell filter.
The expression of VLA-4 and VLA-5 integrins was analyzed in
adherent, nonadherent, and migrating CD341 cells coexpressing
CXCR4. VLA-4 was brightly expressed by most of the cells
(. 99%) in all 3 fractions and with similar MCFR (data not
shown). Small differences were observed in VLA-5 antigen density
among the 3 fractions: MCFR of VLA-5 was 3.6 6 0.7 in the
nonadherent fraction, 4.7 6 0.8 in adherent cells, and 2.8 6 0.2 in
the migrating fraction (P , .05 compared with adherent cells,
n 5 5) (Figure 4). Therefore, the inability of a subset of CD341
CXCR41 cells to migrate across Fn was not caused by down-
regulation of either VLA-4 or VLA-5. On the contrary, VLA-5 was
slightly overexpressed in the adherent fraction.
Adhesion and migration of cycling progenitor cells are
inversely correlated
We next studied Fn binding and migratory activity of activated CB
CD341 cells in relation with cell cycle status. Following adhesion
assay, the cell cycle status of adherent and nonadherent cells was
established by DNA staining with PI (n 5 18). The adhesion
Figure 4. Expression of VLA-4 and VLA-5 integrins in CXCR41 nonadherent,
adherent, and migrating CD341 cells. Transmigration of cultured CD341 cells was
assessed across Fn-coated filters, after which nonadherent (A,B), adherent (C,D),
and migrating cells (E,F) were harvested. Cells were labeled with anti-CXCR4–PE
together with anti–VLA-4–FITC or anti–VLA-5–FITC. Analysis of integrin expression
was restricted to CXCR4-expressing cells by appropriate gating. Staining with
isotype-matched IgG (dotted lines) and with anti–VLA-4 (left plots) or anti–VLA-5
(right plots) is shown in a representative experiment out of 5.
Figure 2. Transmigration of cultured CD341 cells was dependent on the
expression of CXCR4. CB CD341 progenitor cells were stimulated ex vivo during 48
hours and assayed for transmigration across Fn-coated filters toward control medium
(A,C) or MS-5 CM (B,D). Expression of CXCR4 was measured by FACS analysis in
nonmigrating (A,B) and migrating cells (C,D). Staining with irrelevant isotype-
matched IgG-PE (dotted lines) and anti-CXCR4–PE (solid lines) is shown in a
representative experiment (of 7).
Figure 3. Effect of Fn coating concentration on adhesion and migration of
cultured CD341 cells. Transmigration of cultured CD341 cells was determined
toward MS-5 CM across filters coated at the indicated Fn concentrations. After 3
hours, cells were recovered in 3 fractions: migrating (Mg) as well as nonadherent
(Nad) and adherent (Ad) nonmigrating cells. A representative experiment (of 2)
is depicted.
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capacity to Fn of CB CD341 cells increased with cell cycle
progression: 14.7% 6 2.6% in G0/G1, 18.7% 6 2.7% in S (P , .05
compared with G0/G1) and 31.5% 6 4.6% in G2/M (P , .05
compared with both G0/G1 and S) (Figure 5A). Adhesion to a
BSA-coated plate was always less than 2%.
The same experimental design was used to assess the migratory
activity of stimulated CB CD341 cells in different phases of the cell
cycle. Following migration assay toward MS-5 CM in an Fn-coated
transwell, cells recovered from the top and bottom chambers were
assayed for cell cycle status by FACS analysis. Migration de-
creased with cell cycle progression: 44.5% 6 2.5% in G0/G1,
39.1% 6 3.2% in S (P , .05 compared with G0/G1), and
31.0% 6 2.7% in G2/M (P , .05 compared with both G0/G1 and S)
(Figure 5B). This was not due to an inhibitory effect of MS-5 CM
on the cycling status of migrating CD341 cells. Indeed, in control
experiments, when stimulated CD341 cells were incubated for 3
hours in MS-5 CM, the proportion of cells in S/G2/M
(47.0% 6 0.3%) was not different from that of cells incubated in
control medium (46.9% 6 1.0%, n 5 2). Moreover, when the filter
was coated with BSA, migration toward MS-5 CM was similar in
all phases of the cell cycle (26.9% 6 3.7% in G0/G1, 30.5% 6 3.1%
in S, and 26.4% 6 5.2% in G2/M, Figure 5C). These results
demonstrate that Fn overall facilitated transmigration of activated
CD341 cells but at the same time reduced the migrating ability of
S/G2/M cells, whose binding capacity was upregulated as com-
pared with cells in G0/G1.
Adhesive and migratory activities of ex vivo–cultured CB
CD341 cells were compared with those of unstimulated CD341
cells (Table 1). Adhesion to Fn was higher after 48 hours of ex vivo
culture (P , .05). Migration toward MS-5 CM across Fn declined
significantly (P , .05), while no changes in motility were observed
in BSA-coated transwells. This confirms a specific change in Fn
interaction during cell cycle progression of progenitor cells ex vivo.
It has been suggested that culture of hematopoietic cells with Fn
causes accelerated cell cycle progression.20,35,36 To exclude the
possibility that contact with Fn by itself was responsible for the
higher cycling status of adherent or nonmigrating cells (ie, cells
staying in contact with Fn throughout adhesion or migration
assays), activated CD341 cells were stained with Hoechst 33342
and sorted into G0/G1 and S/G2/M subpopulations before measur-
ing the adhesive and migratory capacities of each fraction sepa-
rately. Cycling cells had a 3-fold higher adhesion capacity
(50.2% 6 5.1%) compared with noncycling cells (16.0% 6 2.2%,
P , .05) (Figure 6).Transmigration toward MS-5 CM across BSA
was similar for cycling (19.0% 6 1.1% migration) and noncycling
cells (19.4% 6 0.9% migration, P . .05), whereas in Fn-coated
transwells cycling cells had a reduced migratory capacity as
compared with the noncycling cells (13.8% 6 2.0% vs
33.3% 6 5.8%, P , .05) (Figure 6). Migration of cycling cells
across Fn was even significantly lower than across BSA
(13.8% 6 2.0% vs 19.0 6 1.1%, P , .05). This further suggests
that full adhesion to Fn of cycling CD341 cells inhibited their
migration.
Defective migration of cycling LTC-ICs
Transwell assays toward MS-5 CM were set up with cultured
CD341 cells. Cells recovered in the nonmigrating and migrating
fractions were replated in secondary LTC-IC assays. Migration of
Table 1. Adhesion and migration of unstimulated and ex vivo–expanded
CD341 cells
Cell fraction
Freshly isolated Ex vivo–activated
% adhesion 14.2 6 3.9 36.6 6 5.5*
% migration (Fn) 61.3 6 3.8 37.6 6 1.2*
% migration (BSA) 25.1 6 1.2 21.5 6 0.7
Freshly isolated and ex vivo-activated CD341 cells were assayed for adhesion
on Fn. The migration capacity toward MS-5 CM of each fraction was measured in Fn-
and BSA-coated transwells (n 5 3).
*P , .05 compared with freshly isolated CD341 cells.
Figure 5. Adhesion and migration of cultured CD341 residing in different
phases of the cell cycle. CB CD341 cells were cultured ex vivo for 48 hours and
assayed for Fn binding (n 5 18 [A]) or migration toward MS-5 CM across Fn- (n 5 6
[B]) or BSA-coated filters (n 5 6 [C]). Percent adhesion or migration of cells in G0/G1,
S, and G2/M was calculated relative to the total number of cells in each phase in the
input population. (A) *Adhesion was statistically higher in S than in G0/G1 (P , .05);
**adhesion was statistically higher in G2/M than in G0/G1 and in S (P , .05). (B)
*Migration was statistically lower in S than in G0/G1 (P , .05); **migration was
statistically lower in G2/M than in G0/G1 and in S (P , .05)
Figure 6. Adhesion and migration of FACS-sorted cycling and noncycling
CD341 cells. Cultured CD341 cells were fractionated into noncycling (G0/G1) and
cycling (S/G2/M) fractions by Hoechst sorting (n 5 3). (A) Transmigration of cycling
and noncycling cells toward MS-5 CM was determined across Fn- or BSA-coated
filters. *Migration of noncycling cells was higher than that of cycling cells (P , .0.5);
**migration of cycling cells across Fn was lower than across BSA (P , .0.5). (B) Both
fractions were assayed for adhesion to Fn- or BSA-coated plates. *Fn binding of
cycling cells was higher than that of noncycling cells (P , .05). ND indicates
not detected.
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LTC-ICs toward MS-5 CM was similar across BSA-
(40.5% 6 6.4%) and Fn-coated transwells (40.8% 6 4.7%, n 5 3).
Thus, contrary to what was observed for committed progenitors, Fn
appeared to have no enhancing effect on the transmigration of
overall LTC-ICs.
The cell cycle status of LTC-ICs recovered in the migrating and
nonmigrating fractions was determined by HU killing assays
(Figure 7). In the presence of Fn, migration of noncycling LTC-ICs
was 48.0% 6 2.9% while only 20.5% 6 1.1% of cycling LTC-ICs
were able to migrate toward MS-5 CM (P , .05, n 5 4). On the
opposite, in BSA-coated transwells, migration was increased in
cycling LTC-ICs (53.7% 6 5.2%), compared with noncycling
LTC-ICs (27.9% 6 1.4%) (P , .05, n 5 4). Thus, Fn had a
positive effect on the migration of noncycling LTC-ICs and an
inhibitory effect on that of cycling LTC-ICs. We had previously
reported that Fn binding is 3-fold higher in cycling LTC-ICs
compared with their noncycling counterparts.27 Overall, our data
suggest that the inverse relationship between adhesion and migra-
tion of cycling progenitor cells holds true for the more primitive
LTC-IC subset.
Adhesion and migration of cycling CD341 cells are
independently regulated by VLA-4 and VLA-5 integrins
in dividing cells
Activated CD341 cells were preincubated with nonspecific IgG or
with antibodies blocking either VLA-4 or VLA-5 and assayed for
transmigration activity. In all assays, the cell cycle status of
migrating and nonmigrating cells was assessed by PI staining to
establish whether the effect of blocking antibodies was present in
all phases of the cell cycle (Figure 8A). Interestingly, while the
inhibition provided by anti–VLA-4 antibody was similar in G0/G1
(22.3% 6 4.0% inhibition), in S (26.1% 6 8.5%), and in G2/M
(17.6% 6 6.0%) (n 5 5, P . .05), anti–VLA-5 antibody was less
effective in blocking migration of cells in G2/M (9.9% 6 4.6%
inhibition) compared with cells in G0/G1 (36.2% 6 2.6%, P , .05)
or in S phase (40.3% 6 6.6%, P , .05).
Similar experiments were performed to establish the contribu-
tion of VLA-4 and VLA-5 in mediating adhesion of activated
CD341 cells in various phases of the cell cycle. Anti–VLA-4
treatment resulted in 30.9% 6 11.1% inhibition of Fn binding in
G0/G1 and 38.3% 6 1.1% in S phase, whereas no inhibition was
observed for cells in G2/M (Figure 8B). Anti–VLA-5 was slightly
more effective in blocking cells in S (82.2% 6 3.3% inhibition)
and G21M (84.9% 6 5.0%), compared with G0/G1 cells
(71.0% 6 4.1% inhibition, P , .05).
When comparing migration and adhesion data, the most striking
difference was observed for CD341 cells in G2/M: VLA-5 medi-
ated strong adhesion but not migration of G2/M cells, while the
reverse was shown for VLA-4, ie, VLA-4 was involved in
migration but not in static adhesion of this cell subset. Altogether,
these results suggest that the effect of VLA-4 and VLA-5 integrins
in mediating adhesion and migration of stimulated progenitor cells
onto Fn was modulated in relationship to cell cycle status and
independently of each other.
Chemotaxis of VLA-5dim and VLA-5high cells subfractionated on
the basis of cell cycle status
The observation of a subset of CD341CXCR41VLA-5high cells
unable to migrate across Fn (Figure 4) led us to speculate that
maximal VLA-5 expression induced static adhesion to Fn and
defective motility. To test this hypothesis, CD341 cells were sorted
Figure 7. Migration of cycling and noncycling LTC-ICs. Transmigration toward
MS-5 CM of cultured CD341 cells was determined across BSA- or Fn-coated filters.
Migrating and nonmigrating cells were replated in LTC-IC assays. The cycling fraction
of LTC-ICs was measured by HU killing assays. Data represent percent migration of
cycling and noncycling LTC-ICs (n 5 4). *P , .05 compared with noncycling LTC-IC
either across Fn or BSA.
Figure 8. Role of VLA-4 and VLA-5 in mediating adhesion and transmigration of
CD341 cells in different phases of the cell cycle. (A) Migration of cultured CD341
cells toward MS-5 CM was assayed in Fn-coated transwells during 3 hours, after
which cell cycle status of nonmigrating and migrating cells was determined by PI
staining. Prior to transmigration, cells were incubated with blocking antibodies
against VLA-4 or VLA-5 integrins. Control cells were treated with isotype-matched
control IgG. Percent inhibition of migration was calculated for cells in G0/G1, S, and
G2/M (n 5 5). *Inhibition by anti–VLA-5 was lower in G2/M cells compared with S or
G0/G1 cells (P , .05). (B) Adhesion of cultured CD341 cells to Fn was measured after
neutralization of VLA-4 or VLA-5 by blocking antibodies or incubation with control
IgG. After 1-hour adhesion, the cell cycle status of adherent and nonadherent cells
was determined by PI staining. Data represent the percent inhibition of Fn binding
compared with control IgG in each phase of the cell cycle (n 5 4). *Inhibition of Fn
binding by anti–VLA-4 was lower in G2/M compared with S and G0/G1 cells (P , .05).
**Inhibition of Fn binding by anti–VLA-5 was lower in G0/G1 compared with S and
G2/M (P , .05).
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into VLA-5high and VLA-5low subsets using a nonblocking antibody
(clone VC5; Pharmingen), and migration of both fractions toward
MS-5 CM was assayed across Fn and BSA (Table 2). Migration
across Fn was higher in the CD341 VLA-5low compared with the
CD341VLA-5high fraction (P , .05), while migration of each
subset was similar across BSA. However, compared with the
VLA-5dim fraction, the VLA-5high fraction had a 2-fold enrichment
in cycling cells, which might then underlie their defective migra-
tion capacity. Similar findings have already been reported in
murine HSCs fractionated on the basis of VLA-5 and other
adhesion molecules37 and are mostly due to larger size and higher
fluorescence background of cycling cells compared with
noncycling cells.
To analyze independently the effect of cycle status and VLA-5
expression on transmigration across Fn, CD341VLA-5dim and
CD341VLA-5high cells were each subfractionated into G0/G1 and
S/G21M fractions (Figure 9). The migratory activity of each of the
4 fractions was assessed toward MS-5 CM across Fn-coated
transwells (Table 3). The data clearly show that the expression level
of VLA-5 had no influence on the chemotaxis of activated CD341
cells across Fn, while transit in S/G21M negatively affected cell
motility independently of VLA-5 expression density.
Discussion
In this report, we have shown that cycling committed progenitor
cells as well as LTC-ICs harvested after a 2-day expansion culture
presented defective migration across Fn toward MS-5 CM. We can
rule out the hypothesis that G0/G1 progenitor cells passively
migrate at a higher rate because of their smaller size. Indeed, the
higher migration rate of noncycling progenitor cells was observed
when the transwell filter was coated with Fn whereas, across
BSA-coated filters, migration of noncycling progenitor cells was
similar, or even lower in the case of LTC-ICs, compared with that
of their cycling counterparts. The impaired migratory activity of
cycling progenitor cells was not due to a reduced response to
SDF-1 because, again, migration across BSA toward MS-5 CM
was not defective in this cell population. Thus, the migration defect
of cycling progenitor cells was observed as a result of an active
interaction with Fn. Indeed, when adhesion to Fn was studied in
relation to cell cycle status, it was observed that adhesion of cycling
committed progenitor cells and LTC-ICs was higher compared with
their noncycling counterparts.
A number of studies have been devoted to delineating the
different factors influencing migration rate.30,38 Migration requires
coordinated attachment of the cell front and release of binding sites
at the cell rear. Cell-substratum adhesion strength is critical to this
process because strong binding will retain cells while lower
adhesive force will allow contact with the matrix and easier
detachment of adhesion complexes. The differences in adhesion
and migration described here in cycling and noncycling cells may
thus indicate that adhesion strength to Fn increases during cell
cycle transit, leading to static binding and impairment of cell
migration.
It has been shown that bone marrow implantation is dependent
on intramedullary migration followed by selective retention in
specific endosteal niches.24 If we assume that migration and
adhesion require balanced interactions of both VLA-4 and VLA-5
with Fn, our data may suggest that inactivation of VLA-5–
mediated migration of progenitor cells in G2/M may lead to a
selective homing defect, while the inability of VLA-4 to mediate
static binding to Fn in G2/M CD341 cells might result in defective
retention in the bone marrow. Conversely, VLA-4 and VLA-5 were
simultaneously active in other phases of the cell cycle, in both
Table 2. Migration of CD341 cells expressing low and high levels of VLA-5
Cell fraction
VLA-5low VLA-5high
% S/G2 1 M cells 34.6 6 1.0 62.0 6 1.9
% migration
Fn 38.7 6 1.7* 20.0 6 3.4
BSA 24.1 6 3.4 26.2 6 1.3
Cultured CD341 cells were sorted into VLA-5low and VLA-5high fractions. The
percent cells in S/G2 1 M was determined in each fraction by PI staining. The
migration capacity was assessed toward MS-5 CM across Fn (n 5 6) or BSA (n 5 2).
*P , .05 compared with migration of VLA-5high cells across Fn.
Table 3. Migration across Fn of CD341 cells fractionated on the basis of




CD341 VLA-5low CD341 VLA-5high
G0/G1 S/G2 1 M G0/G1 S/G2 1 M
1 39.0 24.5 38.2 17.2
2 43.6 26.7 35.8 27.1
3 40.3 19.9 40.0 22.7
Mean 40.9* 23.7 38.0* 22.3
SEM 1.4 2.0 1.2 2.9
Cultured CD341 cells were sorted as depicted in Figure 9 into 4 fractions. Data
represent percent migration of each fraction across Fn toward MS-5 CM.
*P , .05 compared with S/G2 1 M in both VLA-5low and VLA-5high subsets.
Figure 9. Fractionation of cultured CD341 cells on the basis of VLA-5 expres-
sion and cell cycle status. Cultured CD341 cells were simultaneously labeled with
anti–VLA-5 and Hoechst 33342. (A) VLA-5 histogram showing gating of CD341
VLAlow (R1) and VLA-5high (R2) cells. (B) DNA histogram of total CD341 cells. (C)
DNA histogram of CD341VLA-5low cells. (D) DNA histogram of CD341VLA-5high cells.
In each of VLA-5low and VLA-5high subsets, noncycling (R3) and cycling (R4) CD341
cells were sorted.
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adhesion and migration assays. It should be noted, however, that
because LTC-ICs represent a small fraction of total CD341 cells,
we cannot provide direct evidence that the observed changes of
integrin function with cell cycle status in cultured CD341 cells
were also present at the LTC-IC level.
When comparing the behavior of committed progenitors and of
LTC-ICs in transmigration assays, it was observed that migration of
LTC-ICs toward MS-5 CM across BSA was higher than that of
CD341 cells. This may suggest that LTC-ICs are more responsive
to SDF-1 than more committed progenitors, which is in accordance
with data reported by Peled et al39 showing that among the CD341
population the CD38low subset had an increased migratory activity
toward SDF-1. In addition, Fn coating of the transwell filter was
not effective in stimulating LTC-IC migration toward MS-5 CM
above levels observed across BSA-coated filters, whereas in more
committed progenitors Fn induced a 2-fold increase in migratory
activity. This difference may result from stronger adhesion of
LTC-ICs than of colony-forming cells to Fn, as described in a
previous paper by our group27 and in other reports.40 Fn may
increase migration of mildly adherent LTC-ICs while retaining
strongly adherent LTC-ICs onto the filter, with no net change in
overall LTC-IC migration.
Yong and coworkers41,42 have studied the migratory activity of
unstimulated and stimulated progenitor cells isolated from various
sources. A consistent finding of these studies was that proliferating
progenitor cells migrated more efficiently than nonproliferating
ones. This difference with our results may arise from the fact that
migration was assessed across endothelial cells by Yong and
colleagues whereas in the present work migration was studied in
Fn-coated transwells. Thus, it is not possible to draw general rules
on the migration ability of cycling and noncycling progenitor cells.
Instead, it is likely that the transmigratory activity will depend on
the cell type or the extracellular matrix protein across which
migration occurs. In addition, transendothelial migration may
represent initial stages of homing, while migration across Fn may
be more important for the final localization of stem/progenitor cells
in the bone marrow environment. Therefore, extrapolation of these
data to in vivo homing mechanisms must be done cautiously.
An apparent discrepancy in our results is that most of the
changes in migration of total CD341 cells occurred during the
G2/M phase while, in the LTC-IC subset, a similar modulation was
observed during S phase. We assume that these differences are due
to different procedures used for cell cycle phase identification. In
LTC-IC experiments, cells were treated with HU, which selectively
eliminates cells in S phase, prior to the migration assay. We believe
that results obtained with this procedure demonstrate unambig-
ously that LTC-ICs in S phase have decreased migratory activity
across Fn. In the case of total CD341 cells, cells were allowed to
migrate, after which the cell cycle status of migrating and
nonmigrating cells was determined by PI staining. Our results show
a gradual decrease in migration during transit from G1 to S and
from S to G2/M. Thus, it may be possible that during a 3-hour
migration assay S phase cells remained in the top chamber and
gradually accumulated in G2/M, which then would lead to an
overestimation of the migration defect of G2/M cells. This hypoth-
esis is supported by another study in which we have shown that
synchronized CD341 cells execute a complete transition from mid
S phase to G2/M in approximately 3 hours.43
The data presented in this paper have important implications for
the engraftment of ex vivo–expanded progenitor cells. It has been
suggested by different authors that VLA-5 plays a physiologic role
in stem cell trafficking.10,15,37,44 Because other studies have ob-
served an engraftment defect of cycling stem/progenitor cells, our
data may suggest that this is partly caused by increased static
adhesion and impaired motility across Fn. Whether such a phenom-
enon applies to the interaction of cycling progenitor cells to other
adhesion molecules remains the subject of further studies and
should provide more detailed knowledge of the homing mecha-
nisms of expanded HSCs.
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